opdivo.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /etc/tags/ Disallow: /apps/ Disallow: /crx/ Disallow: /libs/ Disallow: /bin/ Disallow: /en/pdf/ Disallow: /search-results/jcr:content/searchresults.searchresultsitems.html Sitemap: | ||
Meta Tags
| Title | OPDIVO® |
| Description | OPDIVO® Immunotherapy: Giving People a Choice and a Chance Against Their OPDIVO® (nivolumab) is a prescription medication that treats certain types of cancer. Read the indications, side effects, and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 165.89.235.20 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
opdivo.com Valuation
|
US$241,105,789
Last updated: 2023-04-27 04:16:41
opdivo.com has Semrush global rank of 43,899. opdivo.com has an estimated worth of US$ 241,105,789, based on its estimated Ads revenue. opdivo.com receives approximately 27,819,899 unique visitors each day. Its web server is located in United States, with IP address 165.89.235.20. According to SiteAdvisor, opdivo.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$241,105,789 |
| Daily Ads Revenue | US$222,560 |
| Monthly Ads Revenue | US$6,676,776 |
| Yearly Ads Revenue | US$80,121,309 |
| Daily Unique Visitors | 1,854,660 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| opdivo.com. | A | 86400 | IP: 165.89.235.20 |
| opdivo.com. | NS | 86400 | NS Record: ns1.bms.com. |
| opdivo.com. | NS | 86400 | NS Record: ns4.bms.com. |
| opdivo.com. | NS | 86400 | NS Record: ns3.bms.com. |
| opdivo.com. | NS | 86400 | NS Record: ns2.bms.com. |
| opdivo.com. | TXT | 86400 | TXT Record: facebook-domain-verification=h8n9cmmt24p3sg3qkb31atgho5kbmv |
HtmlToTextCheckTime:2023-04-27 04:16:41
| FULL INDICATIONS U.S. Full Prescribing Information OPDIVO YERVOY Medication Guide OPDIVO YERVOY U.S. Healthcare Professionals 1-855-OPDIVO-1 1-855-OPDIVO-1 SIGN UP COST AND ACCESS CHAT --> Better Understand OPDIVO Complimentary support, tools, and educational resources for anyone considering or currently taking OPDIVO Full Indication U.S. Healthcare Professionals × Full Indications Full Indications For certain adults with advanced non-small cell lung cancer (NSCLC) OPDIVO ® (nivolumab) is a prescription medicine used in combination with YERVOY ® (ipilimumab) as a first treatment for adults with a type of advanced stage lung cancer (called non-small cell lung cancer) when your lung cancer has spread to other parts of your body (metastatic) and your tumors are positive for PD-L1, but do not have an abnormal EGFR or ALK gene. OPDIVO ® (nivolumab) is a prescription medicine used in combination with YERVOY ® (ipilimumab) and 2 cycles of chemotherapy that contains platinum and another |
HTTP Headers
HTTP/1.0 301 Moved Permanently Location: http://www.opdivo.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.1 301 Moved Permanently Server: CloudFront Date: Wed, 20 Oct 2021 11:12:13 GMT Content-Type: text/html Content-Length: 183 Connection: close Location: https://www.opdivo.com/ X-Cache: Redirect from cloudfront Via: 1.1 17256fd1010bade0d64432a8527fd53c.cloudfront.net (CloudFront) X-Amz-Cf-Pop: ORD52-C2 X-Amz-Cf-Id: m1_3tERzu4QgzakS62f3HaKAqdcwGQV-CgAFKOFjyXML66szRhNQIA== HTTP/2 200 content-type: text/html;charset=utf-8 content-length: 124462 date: Wed, 20 Oct 2021 11:12:13 GMT server: Apache x-content-type-options: nosniff accept-ranges: bytes x-dispatcher: dispatcher3useast1 x-dispatcher-number: 3 x-vhost: publish x-frame-options: SAMEORIGIN content-security-policy: frame-ancestors https://doctorunite.com https://generationnp.com https://paunite.com https://pathologistconnect.com https://oncologynation.com https://medicaldirectorsforum.com https://oncologynationsandbox.skipta.com https://www.opdivoclinicaldata.com https://www.opdivoyervoymnsclc.com origin-opdivo-customerconnect-bms-aem-prod.adobecqms.net www.opdivo.com; default-src https: blob: wss: 'unsafe-inline' 'unsafe-eval'; media-src https: blob:; font-src https: data:;frame-src * data:; strict-transport-security: max-age=63072000; includeSubDomains; preload cache-control: max-age=0,s-maxage=0 vary: Accept-Encoding,User-Agent x-cache: Miss from cloudfront via: 1.1 6fd3e892e833323ba7dcdc6f465cfe99.cloudfront.net (CloudFront) x-amz-cf-pop: ORD52-C2 x-amz-cf-id: A4H-uSQGTZsR4VBSqr7cyuoUyVa7nfZIAWeNX2q-n1Myt11A4D70qg== |
opdivo.com Whois Information
Domain Name: OPDIVO.COM Registry Domain ID: 1757334616_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2020-11-02T06:51:34Z Creation Date: 2012-11-06T02:19:18Z Registry Expiry Date: 2021-11-06T02:19:18Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BMS.COM Name Server: NS2.BMS.COM Name Server: NS3.BMS.COM Name Server: NS4.BMS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-09T00:08:08Z <<< |